Revenue growth accelerated to 63.5% in 2026Q1, while gross margins expanded to 38.2% from 25.5% in 2023Q4, indicating improved operational maturity.
| Sales/Revenue | 679.58M | 601.8M | 436.21M | 244.59M | 211M | 62.24M | 35.16M | 48.4M |
| Revenue Growth % | 45.83% | 37.96% | 78.34% | 15.92% | 239.02% | 77.01% | -27.35% | - |
| Cost of Goods Sold | 431.15M | 394.62M | 320.06M | 193.18M | 192.01M | 64.13M | 46.98M | 49.48M |
| COGS % of Revenue | - | 65.57% | 73.37% | 78.98% | 91% | 103.04% | 133.61% | 102.22% |
| Gross Profit | 248.43M | 207.18M | 116.15M | 51.41M | 18.99M | -1.89M | -11.82M | -1.08M |
| Gross Margin % | 36.56% | 34.43% | 26.63% | 21.02% | 9% | -3.04% | -33.61% | -2.22% |
| Gross Profit Growth % | - | 78.38% | 125.93% | 170.72% | 1103.17% | 83.98% | -998.23% | - |
| Operating Expenses | 474.05M | 436.02M | 305.95M | 229.33M | 154.19M | 100.16M | 43.13M | 31.72M |
| OpEx % of Revenue | - | 72.45% | 70.14% | 93.76% | 73.08% | 160.93% | 122.68% | 65.54% |
| Selling, General & Admin | 177.93M | 165.3M | 131.56M | 110.27M | 89.03M | 58.4M | 23.99M | 19.09M |
| SG&A % of Revenue | - | 27.47% | 30.16% | 45.08% | 42.19% | 93.83% | 68.24% | 39.44% |
| Research & Development | 296.12M | 270.72M | 174.39M | 119.05M | 65.17M | 41.77M | 19.14M | 12.73M |
| R&D % of Revenue | - | 44.98% | 39.98% | 48.67% | 30.89% | 67.11% | 54.44% | 26.3% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -95K |
| Operating Income | -225.62M | -228.84M | -189.8M | -177.92M | -135.2M | -102.05M | -54.95M | -32.89M |
| Operating Margin % | -33.2% | -38.03% | -43.51% | -72.74% | -64.08% | -163.97% | -156.29% | -67.96% |
| Operating Income Growth % | - | -20.57% | -6.68% | -31.59% | -32.48% | -85.71% | -67.06% | - |
| EBITDA | -175.53M | -184.9M | -156.15M | -148.17M | -105.26M | -91.2M | -45.61M | -28.02M |
| EBITDA Margin % | -25.83% | -30.73% | -35.8% | -60.58% | -49.89% | -146.54% | -129.73% | -57.9% |
| EBITDA Growth % | -2.13% | -18.42% | -5.38% | -40.77% | -15.41% | -99.95% | -62.78% | - |
| D&A (Non-Cash Add-back) | 50.09M | 43.94M | 33.66M | 29.74M | 29.95M | 10.85M | 9.34M | 4.87M |
| EBIT | -212.46M | -199.41M | -185.46M | -174.67M | -125.15M | -102.05M | -54.95M | -32.89M |
| Net Interest Income | 10.48M | -977K | -3.95M | -4.25M | -7.8M | -6.13M | 224K | 2.79M |
| Interest Income | 19.74M | 25.51M | 0 | 0 | 0 | 0 | 224K | 2.79M |
| Interest Expense | 9.25M | 26.49M | 3.95M | 4.25M | 7.8M | 6.13M | 0 | 0 |
| Other Income/Expense | 14.34M | 2.94M | 390K | -1M | 2.26M | -22.79M | 414K | 2.89M |
| Pretax Income | -211.28M | -225.9M | -189.41M | -178.92M | -132.95M | -124.84M | -54.54M | -30.01M |
| Pretax Margin % | -31.09% | -37.54% | -43.42% | -73.15% | -63.01% | -200.59% | -155.11% | -62% |
| Income Tax | -28.67M | -27.69M | 764K | 3.65M | 3M | -7.52M | 467K | 354K |
| Effective Tax Rate % | 13.57% | 12.26% | -0.4% | -2.04% | -2.26% | 6.02% | -0.86% | -1.18% |
| Net Income | -182.62M | -198.21M | -190.18M | -182.57M | -135.94M | -117.32M | -55.01M | -30.36M |
| Net Margin % | -26.87% | -32.94% | -43.6% | -74.64% | -64.43% | -188.51% | -156.44% | -62.73% |
| Net Income Growth % | 11.58% | -4.22% | -4.17% | -34.3% | -15.87% | -113.29% | -81.18% | - |
| Net Income (Continuing) | -182.62M | -198.21M | -190.18M | -182.57M | -135.94M | -117.32M | -55.01M | -30.36M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.30 | -0.37 | -0.38 | -0.38 | -0.29 | -0.26 | -0.12 | -0.08 |
| EPS Growth % | 18.04% | 2.63% | 0% | -31.03% | -11.54% | -116.67% | -58.31% | - |
| EPS (Basic) | - | -0.37 | -0.38 | -0.38 | -0.29 | -0.26 | -0.12 | -0.08 |
| Diluted Shares Outstanding | 605.43M | 530.66M | 495.93M | 481.77M | 466.21M | 452.21M | 447.92M | 400.83M |
| Basic Shares Outstanding | 605.43M | 530.66M | 495.93M | 481.77M | 466.21M | 452.21M | 447.92M | 400.83M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
Neutron development capital intensity
As indicated by recent quarterly filings, Rocket Lab achieved a 63.5% year-over-year revenue growth rate in 2026Q1, signaling that the company is successfully transitioning from a niche launch provider into a broader aerospace systems integrator with increasing top-line momentum across its dual-segment business model.
The acceleration in revenue suggests that the Space Systems segment is effectively capturing market share, likely benefiting from the high switching costs associated with integrated satellite components. Investors should monitor whether this growth trajectory remains sustainable as the company scales its launch cadence and integrates larger constellation contracts into its revenue recognition cycle.
Based on reported financial data, gross margins have steadily improved from 25.5% in 2023Q4 to 38.2% in 2026Q1, suggesting that the company is gaining better control over its manufacturing costs and benefiting from the higher-margin profile inherent in its expanding Space Systems component business.
This margin expansion appears to indicate that the company is successfully absorbing fixed costs through higher production volumes. However, the sustainability of these gains may depend on the company's ability to maintain pricing power in the competitive small-satellite market while managing the specialized material costs required for its next-generation launch vehicle.
According to the income statement, operating losses remain persistent at $56.0 million for 2026Q1, as the company continues to prioritize heavy investment in the Neutron program, which currently offsets the operational efficiencies gained from the scaling of the Electron launch and Space Systems segments.
The lack of positive operating income suggests that the company is in a high-growth investment phase where R&D expenditures are prioritized over immediate profitability. Analysts should evaluate whether the current level of SG&A and R&D spending is a temporary necessity for product development or a structural hurdle that may delay the path to operating breakeven.
As reported in recent financial statements, R&D expenses have climbed to $80.5 million in 2026Q1, reflecting the significant capital commitment required to advance the Neutron launch vehicle and Archimedes engine development, which remains the primary driver of the company's current cost structure.
The elevated R&D spend appears to be a deliberate strategic choice to secure long-term competitive advantages in the medium-lift launch market. Investors should consider that while these costs are currently weighing on the bottom line, they may represent a critical investment in future revenue-generating assets that could eventually provide significant operating leverage.
Based on an analysis of the income statement, the primary risk remains the potential for prolonged cash burn, as the company's reliance on heavy R&D spending for the Neutron program may necessitate future capital raises if revenue growth fails to outpace the current rate of expenditure.
Short-term volatility in net income, as seen in the fluctuations between 2025Q2 and 2026Q1, suggests that the company's path to profitability is sensitive to milestone-based revenue recognition and development timelines. Any delays in the Neutron program could lead to a mismatch between capital availability and operational requirements, warranting a cautious outlook on the company's long-term cash runway.
Quick answers to the most common questions about buying RKLB stock.
For fiscal year 2025, Rocket Lab USA, Inc. (RKLB) reported total revenue of $601.8M. This represents a 1143.4% increase compared to $48.4M in 2019.
Rocket Lab USA, Inc. (RKLB) reported a net loss of $198.2M for the fiscal year ending 2025.
Rocket Lab USA, Inc. (RKLB) reported an operating income of $-228.8M, resulting in an operating profit margin of -38.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Rocket Lab USA, Inc. (RKLB) generated $207.2M in gross profit for the year, representing a gross profit margin of 34.4%. This demonstrates the company's core pricing power and production efficiency.